abstract |
The present application describes a novel compound that modulates (in particular, inhibits) Sirt2, having the structures according to formulae (1) and (2) described herein. The present invention also relates to pharmaceutical compositions thereof, methods of treatment (ie, cancer and neurodegenerative diseases) by administration of modulating compounds, assays for finding modulators of Sirt2, and kits for carrying out said assays. |